Global Transdermal Drug Delivery Industry

Tuesday, July 30, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, July 29, 2019 /PRNewswire/ -- Transdermal Drug Delivery market worldwide is projected to grow by US$3 Billion, guided by a compounded growth of 7. Download the full report: https://www.reportbuyer.com/product/5799828/?utm_source=PRN 5%. Staying on top of trends is essential for decision makers to leverage this emerging opportunity. The report addresses this very need and provides

the latest scoop on all major market segments. Cardiovascular, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$2 Billion by the year 2025, Cardiovascular will bring in healthy gains adding significant momentum to global growth. - While global megatrends sweeping through the market influence the primary direction of growth, regional markets are swayed by more granular locally unique business drivers. Representing the developed world, the United States will maintain a 9.3% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$225.5 Million to the region's size and clout in the next 5 to 6 yearsOver US$374.4 Million worth of projected demand in the region will come from other emerging Eastern European markets. In Japan, Cardiovascular will reach a market size of US$139.9 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.1% over the next couple of years and add approximately US$504.3 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies. - Competitors identified in this market include among others, Antares Pharma, Inc. (USA); Bayer AG (Germany); Durect Corporation (USA); Iontera, Inc. (USA); Janssen Pharmaceuticals, Inc. (USA); Nitto Denko Corporation (Japan); Novartis AG (Switzerland); Pantec Biosolutions AG (Liechtenstein); Tesa Labtec GmbH (Germany); Teva Pharmaceutical Industries Ltd. (Israel)Download the full report: https://www.reportbuyer.com/product/5799828/?utm_source=PRN TRANSDERMAL DRUG DELIVERY MARKET ANALYSIS, TRENDS, AND FORECASTS, JULY 2019CONTENTSI. METHODOLOGYII. EXECUTIVE SUMMARY1. MARKET OVERVIEWGlobal Competitor Market SharesTranscritical CO2 Systems Competitor Market Share ScenarioWorldwide (in %): 2019 & 20252. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVETable 1: Transdermal Drug Delivery Global Market Estimates and Forecasts in $ Million by Region/Country: 2018-2025 Table 2: Transdermal Drug Delivery Global Retrospective Market Scenario in $ Million by Region/Country: 2009-2017 Table 3: Transdermal Drug Delivery Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 Table 4: Cardiovascular (End-Use) Global Opportunity Assessment in $ Million by Region/Country: 2018-2025 Table 5: Cardiovascular (End-Use) Historic Sales Analysis in $ Million by Region/Country: 2009-2017 Table 6: Cardiovascular (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025 Table 7: CNS (End-Use) Worldwide Sales in $ Million by Region/Country: 2018-2025 Table 8: CNS (End-Use) Historic Demand Patterns in $ Million by Region/Country: 2009-2017 Table 9: CNS (End-Use) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025 Table 10: Dermatology (End-Use) Demand Potential Worldwide in $ Million by Region/Country: 2018-2025 Table 11: Dermatology (End-Use) Historic Sales Analysis in $ Million by Region/Country: 2009-2017 Table 12: Dermatology (End-Use) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025 Table 13: Other End-Uses (End-Use) Worldwide Latent Demand Forecasts in $ Million by Region/Country: 2018-2025 Table 14: Other End-Uses (End-Use) Global Historic Analysis in $ Million by Region/Country: 2009-2017 Table 15: Other End-Uses (End-Use) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025 Table 16: Pain Management (End-Use) Global Market Estimates & Forecasts in $ Million by Region/Country: 2018-2025 Table 17: Pain Management (End-Use) Retrospective Demand Analysis in $ Million by Region/Country: 2009-2017 Table 18: Pain Management (End-Use) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 III. MARKET ANALYSISGEOGRAPHIC MARKET ANALYSIS UNITED STATES MARKET Facts & Figures US Transcritical CO2 Systems Market Share (in %) by Company: 2019 & 2025 Table 19: United States Transdermal Drug Delivery Latent Demand Forecasts in $ Million by End-Use: 2018 to 2025 Table 20: Transdermal Drug Delivery Historic Demand Patterns in the United States by End-Use in $ Million for 2009-2017 Table 21: Transdermal Drug Delivery Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025 CANADA Table 22: Canadian Transdermal Drug Delivery Market Quantitative Demand Analysis in $ Million by End-Use: 2018 to 2025 Table 23: Transdermal Drug Delivery Market in Canada: Summarization of Historic Demand Patterns in $ Million by End-Use for 2009-2017 Table 24: Canadian Transdermal Drug Delivery Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 JAPAN Table 25: Japanese Demand Estimates and Forecasts for Transdermal Drug Delivery in $ Million by End-Use: 2018 to 2025 Table 26: Japanese Transdermal Drug Delivery Market in $ Million by End-Use: 2009-2017 Table 27: Transdermal Drug Delivery Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025 CHINA Table 28: Chinese Demand for Transdermal Drug Delivery in $ Million by End-Use: 2018 to 2025 Table 29: Transdermal Drug Delivery Market Review in China in $ Million by End-Use: 2009-2017 Table 30: Chinese Transdermal Drug Delivery Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 EUROPE MARKET Facts & Figures European Transcritical CO2 Systems Market: Competitor Market Share Scenario (in %) for 2019 & 2025 Table 31: European Transdermal Drug Delivery Market Demand Scenario in $ Million by Region/Country: 2018-2025 Table 32: Transdermal Drug Delivery Market in Europe: A Historic Market Perspective in $ Million by Region/Country for the Period 2009-2017 Table 33: European Transdermal Drug Delivery Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 Table 34: European Transdermal Drug Delivery Addressable Market Opportunity in $ Million by End-Use: 2018-2025 Table 35: Transdermal Drug Delivery Market in Europe: Summarization of Historic Demand in $ Million by End-Use for the Period 2009-2017 Table 36: European Transdermal Drug Delivery Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 FRANCE Table 37: Transdermal Drug Delivery Quantitative Demand Analysis in France in $ Million by End-Use: 2018-2025 Table 38: French Transdermal Drug Delivery Historic Market Review in $ Million by End-Use: 2009-2017 Table 39: French Transdermal Drug Delivery Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 GERMANY Table 40: Transdermal Drug Delivery Market in Germany: Annual Sales Estimates and Forecasts in $ Million by End-Use for the Period 2018-2025 Table 41: German Transdermal Drug Delivery Market in Retrospect in $ Million by End-Use: 2009-2017 Table 42: Transdermal Drug Delivery Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025 ITALY Table 43: Italian Demand for Transdermal Drug Delivery in $ Million by End-Use: 2018 to 2025 Table 44: Transdermal Drug Delivery Market Review in Italy in $ Million by End-Use: 2009-2017 Table 45: Italian Transdermal Drug Delivery Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 UNITED KINGDOM Table 46: United Kingdom Demand Estimates and Forecasts for Transdermal Drug Delivery in $ Million by End-Use: 2018 to 2025 Table 47: United Kingdom Transdermal Drug Delivery Market in $ Million by End-Use: 2009-2017 Table 48: Transdermal Drug Delivery Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025 REST OF EUROPE Table 49: Rest of Europe Transdermal Drug Delivery Addressable MARKET Opportunity in $ Million by End-Use: 2018-2025 Table 50: Transdermal Drug Delivery Market in Rest of Europe: Summarization of Historic Demand in $ Million by End-Use for the Period 2009-2017 Table 51: Rest of Europe Transdermal Drug Delivery Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 ASIA-PACIFIC Table 52: Transdermal Drug Delivery Quantitative Demand Analysis in Asia-Pacific in $ Million by End-Use: 2018-2025 Table 53: Asia-Pacific Transdermal Drug Delivery Historic MARKET Review in $ Million by End-Use: 2009-2017 Table 54: Asia-Pacific Transdermal Drug Delivery Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 REST OF WORLD Table 55: Rest of World Transdermal Drug Delivery Market Quantitative Demand Analysis in $ Million by End-Use: 2018 to 2025 Table 56: Transdermal Drug Delivery Market in Rest of World: Summarization of Historic Demand Patterns in $ Million by End-Use for 2009-2017 Table 57: Rest of World Transdermal Drug Delivery Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 IV. COMPETITIONADVANSOR A/S BITZER KüHLMASCHINENBAU GMBH BALTIMORE AIRCOIL COMPANY CARNOT REFRIGERATION CARRIER COMMERCIAL REFRIGERATION EUROPE CLARIANT AG DANFOSS GMBH DOWDUPONT EMERSON CLIMATE TECHNOLOGIES GREEN & COOL HALLIBURTON HENRY TECHNOLOGIES KEMIRA OYJ LMP SYSTEMS INC. MAYEKAWA MFG. NALCO AN ECLOAB COMPANY PARKER HANNIFIN CORPORATION SCM FRIGO S.P.A SCHLUMBERGER SHECCO SPRL STEPAN COMPANY THE LUBRIZOL CORPORATION V. CURATED RESEARCHDownload the full report: https://www.reportbuyer.com/product/5799828/?utm_source=PRN About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/global-transdermal-drug-delivery-industry-300892494.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store